Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 59
15
Diseases
48
Unique genes
0.099
Avg. similarity score
Hypomyelinating leukodystrophy
Most-connected disease (13 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hypomyelinating leukodystrophy
Leukodystrophy
Tremor-ataxia-central hypomyelination syndrome
POLR3A-related disorder
Wiedemann-rautenstrauch syndrome
POLR3B-related disorder
hypomyelinating leukodystrophy 9
leukodystrophy, hypomyelinating, 18
Developmental delay with dysmorphic facies and brain anomalies
VPS11-related neurological disorder
hypomyelinating leukodystrophy 5
leukodystrophy, hypomyelinating, 14
leukodystrophy, hypomyelinating, 17
leukodystrophy, hypomyelinating, 21
leukodystrophy, hypomyelinating, 22
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hypomyelinating leukodystrophy | 13 | 13 | 30 |
| Leukodystrophy | 8 | 8 | 26 |
| Tremor-ataxia-central hypomyelination syndrome | 5 | 5 | 2 |
| POLR3A-related disorder | 4 | 4 | 1 |
| Wiedemann-rautenstrauch syndrome | 4 | 4 | 1 |
| POLR3B-related disorder | 3 | 3 | 1 |
| hypomyelinating leukodystrophy 9 | 2 | 2 | 1 |
| leukodystrophy, hypomyelinating, 18 | 2 | 2 | 1 |
| Developmental delay with dysmorphic facies and brain anomalies | 1 | 1 | 1 |
| VPS11-related neurological disorder | 1 | 1 | 1 |
| hypomyelinating leukodystrophy 5 | 1 | 1 | 1 |
| leukodystrophy, hypomyelinating, 14 | 1 | 1 | 1 |
| leukodystrophy, hypomyelinating, 17 | 1 | 1 | 1 |
| leukodystrophy, hypomyelinating, 21 | 1 | 1 | 1 |
| leukodystrophy, hypomyelinating, 22 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| POLR3A | 5 / 15 | Hypomyelinating leukodystrophy, Leukodystrophy, POLR3A-related disorder, Tremor-ataxia-central hypomyelination syndrome and 1 more |
| POLR3B | 4 / 15 | Hypomyelinating leukodystrophy, Leukodystrophy, POLR3B-related disorder, Tremor-ataxia-central hypomyelination syndrome |
| DEGS1 | 3 / 15 | Hypomyelinating leukodystrophy, Leukodystrophy, leukodystrophy, hypomyelinating, 18 |
| RARS1 | 3 / 15 | Hypomyelinating leukodystrophy, hypomyelinating leukodystrophy 9, Leukodystrophy |
| AIMP2 | 2 / 15 | Hypomyelinating leukodystrophy, leukodystrophy, hypomyelinating, 17 |
| CLDN11 | 2 / 15 | Hypomyelinating leukodystrophy, leukodystrophy, hypomyelinating, 22 |
| HSPD1 | 2 / 15 | Hypomyelinating leukodystrophy, Leukodystrophy |
| HYCC1 | 2 / 15 | Hypomyelinating leukodystrophy, hypomyelinating leukodystrophy 5 |
| POLR3K | 2 / 15 | Hypomyelinating leukodystrophy, leukodystrophy, hypomyelinating, 21 |
| PYCR2 | 2 / 15 | Hypomyelinating leukodystrophy, Leukodystrophy |
| TMEM163 | 2 / 15 | Hypomyelinating leukodystrophy, Leukodystrophy |
| TMEM63A | 2 / 15 | Hypomyelinating leukodystrophy, Leukodystrophy |
| U2AF2 | 2 / 15 | Developmental delay with dysmorphic facies and brain anomalies, Leukodystrophy |
| UFM1 | 2 / 15 | Hypomyelinating leukodystrophy, leukodystrophy, hypomyelinating, 14 |
| VPS11 | 2 / 15 | Hypomyelinating leukodystrophy, VPS11-related neurological disorder |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cytosolic tRNA aminoacylation | Reactome | 6 / 24 | 62.6× | 3.76e-10 | 4.72e-8 ✓ sig. |
| RNA polymerase | KEGG | 5 / 34 | 36.8× | 2.10e-7 | 1.25e-5 ✓ sig. |
| Cytosolic sensors of pathogen-associated DNA | Reactome | 4 / 22 | 45.5× | 1.56e-6 | 7.13e-5 ✓ sig. |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | Reactome | 4 / 27 | 37.1× | 3.68e-6 | 1.48e-4 ✓ sig. |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | Reactome | 4 / 28 | 35.7× | 4.29e-6 | 1.67e-4 ✓ sig. |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | Reactome | 4 / 28 | 35.7× | 4.29e-6 | 1.67e-4 ✓ sig. |
| Sphingolipid metabolism | KEGG | 4 / 54 | 18.5× | 6.13e-5 | 1.51e-3 ✓ sig. |
| Aminoacyl-tRNA biosynthesis | KEGG | 4 / 66 | 15.2× | 1.35e-4 | 2.86e-3 ✓ sig. |
| RNA Polymerase I Transcription Termination | Reactome | 3 / 32 | 23.5× | 2.74e-4 | 4.99e-3 ✓ sig. |
| Cytosolic DNA-sensing pathway | KEGG | 4 / 83 | 12.1× | 3.27e-4 | 5.75e-3 ✓ sig. |
| RNA Polymerase I Transcription Initiation | Reactome | 3 / 45 | 16.7× | 7.56e-4 | 1.10e-2 ✓ sig. |
| Glycosphingolipid metabolism | Reactome | 3 / 46 | 16.3× | 8.06e-4 | 1.16e-2 ✓ sig. |
| Defective SLC9A6 causes X-linked, syndromic mental retardation,, Christianson type (MRXSCH) | Reactome | 1 / 1 | 250× | 4.00e-3 | 3.77e-2 ✓ sig. |
| Defective HEXA causes GM2G1 | Reactome | 1 / 1 | 250× | 4.00e-3 | 3.77e-2 ✓ sig. |
| RNA Polymerase I Promoter Escape | Reactome | 3 / 91 | 8.2× | 5.69e-3 | 4.77e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| DNA-templated transcription | GO:0006351 | 6 / 113 | 20.7× | 4.27e-7 | 4.08e-5 ✓ sig. |
| tRNA aminoacylation for protein translation | GO:0006418 | 4 / 36 | 43.3× | 2.12e-6 | 1.51e-4 ✓ sig. |
| protein import into mitochondrial intermembrane space | GO:0045041 | 2 / 3 | 260× | 1.94e-5 | 8.74e-4 ✓ sig. |
| lysosome organization | GO:0007040 | 4 / 65 | 24.0× | 2.31e-5 | 1.00e-3 ✓ sig. |
| myelination | GO:0042552 | 4 / 73 | 21.3× | 3.66e-5 | 1.43e-3 ✓ sig. |
| organelle fusion | GO:0048284 | 2 / 4 | 195× | 3.86e-5 | 1.48e-3 ✓ sig. |
| translation | GO:0006412 | 6 / 310 | 7.5× | 1.36e-4 | 3.80e-3 ✓ sig. |
| positive regulation of interferon-beta production | GO:0032728 | 3 / 41 | 28.5× | 1.58e-4 | 4.27e-3 ✓ sig. |
| regulation of SNARE complex assembly | GO:0035542 | 2 / 12 | 64.9× | 4.19e-4 | 8.50e-3 ✓ sig. |
| tRNA aminoacylation | GO:0043039 | 2 / 13 | 59.9× | 4.95e-4 | 9.50e-3 ✓ sig. |
| transcription by RNA polymerase I | GO:0006360 | 2 / 15 | 51.9× | 6.64e-4 | 1.15e-2 ✓ sig. |
| endosomal vesicle fusion | GO:0034058 | 2 / 15 | 51.9× | 6.64e-4 | 1.15e-2 ✓ sig. |
| negative regulation of intracellular estrogen receptor signaling pathway | GO:0033147 | 2 / 15 | 51.9× | 6.64e-4 | 1.15e-2 ✓ sig. |
| response to toxic substance | GO:0009636 | 3 / 83 | 14.1× | 1.27e-3 | 1.75e-2 ✓ sig. |
| positive regulation of macrophage activation | GO:0043032 | 2 / 21 | 37.1× | 1.32e-3 | 1.78e-2 ✓ sig. |